-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 15, Shanghai Pharmaceuticals issued an announcement stating that its wholly-owned subsidiary, Shanghai Pharmaceuticals Dongying, was approved for the imitation of Parecoxib Sodium for injection, which was submitted for production in 4 categories, and it was deemed to have been reviewed.
The 570 billion injection market has set off a wave of criticism, and 4 categories are the hottest
Sales of terminal chemical injections in public medical institutions in China (unit: 100 million yuan)
As the country's centralized procurement has become normal, the consistency evaluation of medicines has continued to accelerate, and the consistency evaluation of injections has increased at an alarming rate
In the first half of 2021, the distribution of injection therapy fields (large categories) is over-evaluated
Pharmaceutical companies "get together" 7 major injection varieties, Qilu, Kelun, Yangtze River.
Over-evaluated injection varieties in the first half of 2021
Note: Calculated based on the status start date
From the perspective of therapeutic fields (subcategories), the 114 injections reviewed in the first half of the year involved 34 subcategories
Judging from the company's review situation, Qilu Pharmaceutical, Kelun Pharmaceutical, and Yangzijiang Pharmaceutical rank in the top three, with 21, 18, and 16 injections that have been reviewed
In the first half of 2021, there are 10 or more injection products that have been evaluated
In addition, dexmedetomidine hydrochloride injection has been reviewed by 9 companies; azithromycin for injection and pantoprazole sodium for injection have been reviewed by 7 companies; docetaxel injection, ropivacaine hydrochloride injection, Cefazolin sodium for injection has been reviewed by 6 companies; caffeine citrate injection, linezolid glucose injection, decitabine for injection, gemcitabine hydrochloride for injection, and levofloxacin sodium chloride injection have 5 companies.
Sales of parecoxib sodium for terminal injection in public medical institutions in China in recent years (unit: 100 million yuan)
On July 15, Shanghai Pharmaceuticals issued an announcement stating that its wholly-owned subsidiary, Shanghai Pharmaceuticals Dongying, had been approved for imitating Parecoxib Sodium for injection, which was approved for production in Category 4, which was deemed to have been reviewed
Sales of terminal ambroxol hydrochloride injection in Chinese public medical institutions in recent years (unit: 100 million yuan)
According to data from Menet.
According to statistics, a total of 46 injections were included in the five batches of national centralized procurement.
